Abstract Number: 2021 • 2017 ACR/ARHP Annual Meeting
Reliability of Ultrasound Elementary Lesions in Gout: Results from an Inter- and Intra-Reading International Multicenter Exercise By 62 Sonographers
Background/Purpose: The OMERACT ultrasound (US) Gout Task Force has defined four US elementary lesions to evaluate patients with gout: double contour (DC), aggregates, tophus and…Abstract Number: 2022 • 2017 ACR/ARHP Annual Meeting
Diagnostic and Prognostic VALUE of Salivary GLAND Ultrasonography in Primary Sjögren’s Syndrome: a Preliminary Study
Background/Purpose: In recent years, salivary gland ultrasonography (SGUS) has emerged as a promising tool for the diagnosis and prognostic stratification of patiens with primary Sjögren’s…Abstract Number: 2023 • 2017 ACR/ARHP Annual Meeting
Diagnostic Value of the Non-Observation of the Frontal Branch of the Temporal Arteries By Ultrasonography in the Diagnostic of Giant Cell Arteritis (GCA)
Background/Purpose: The absence of the parietal branch of the temporal artery during an ultrasound evaluation may be due to a variance of the normal anatomy…Abstract Number: 2024 • 2017 ACR/ARHP Annual Meeting
Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain – an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial
Background/Purpose: Tumor necrosis factor inhibitors (TNFi) signify a major advance in the treatment of rheumatoid arthritis (RA). However, treatment success initially remains uncertain as one…Abstract Number: 2025 • 2017 ACR/ARHP Annual Meeting
Potential Clinical Utility of Manu-Scan, the Novel Optical Molecular Imaging, in Patients with Hand Rheumatoid Arthritis
Background/Purpose: Recently, optical molecular imaging is expected to serve as the new technique for early diagnosis and treatment monitoring of rheumatoid arthritis (RA). "Manu-Scan" is…Abstract Number: 2026 • 2017 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Rates: Improving Safety in Immunocompromised Patients
Background/Purpose: Streptococcus pneumoniae is the most common cause of bacterial pneumonia.1 Invasive pneumococcal infections carry a 10% mortality rate, which is higher in the immunosuppressed.1…Abstract Number: 2027 • 2017 ACR/ARHP Annual Meeting
Pre-Visit Planning Improves Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematosus
Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) lupus are up to 13 times more likely to develop invasive pneumococcal infections, resulting in increased morbidity and…Abstract Number: 2028 • 2017 ACR/ARHP Annual Meeting
Compliance with Pneumococcal Vaccination in Rheumatic Disease Patients on Immunosuppressive Medications
Background/Purpose: The 2012 recommendations of the Centers for Disease Control (CDC) advise that adults aged ≥19 years with immunocompromising conditions including patients on iatrogenic immunosuppression…Abstract Number: 2029 • 2017 ACR/ARHP Annual Meeting
Improved Provider Awareness and Delivery of Zoster Vaccination in Patients with Rheumatoid Arthritis Contemplating Biologic Therapy: Need to Target Eligible Patients Prescribed for Vaccination Post-Clinic
Background/Purpose: Vaccination against herpes zoster (shingles) can reduce the frequency of infection, the severity of shingles should it occur, and the frequency of post-herpetic neuralgia.…Abstract Number: 2030 • 2017 ACR/ARHP Annual Meeting
Patient Motivation in Inflammatory Arthritis: The Use of Ultrasound-Guided Patient Education to Endorse Medication Adherence and Facilitate Cost-Effective Targeted Management
Background/Purpose: To assess the value of sharing the real-time ultrasound (US) images of the inflamed joints/ tendons with inflammatory arthritis patients and its impact on:…Abstract Number: 2031 • 2017 ACR/ARHP Annual Meeting
Online Viewing of Labs in RA Patients Is Not Associated with Clinically Significant Change in ESR over 18 Months Compared to Non-Viewers
Background/Purpose: As part of passage of the Affordable Care Act in 2010, Meaningful Use Core Measures were outlined to improve electronic medical record (EMR)…Abstract Number: 2032 • 2017 ACR/ARHP Annual Meeting
Evaluation of RA Outcome Measures between Users and Non-Users of the Patient Portal
Background/Purpose: Patient engagement has become a growing focus in healthcare, catalyzed with the passage of the Affordable Care Act in 2010. Stage 2 of…Abstract Number: 2033 • 2017 ACR/ARHP Annual Meeting
Low Health Literacy Does Not Impact Adherence to Hydroxychloroquine in Patients with Systemic Lupus
Background/Purpose: Low health literacy has been associated with poor health outcomes and increased hospital admissions. Adherence to medication has been shown to significantly impact mortality, morbidity,…Abstract Number: 2034 • 2017 ACR/ARHP Annual Meeting
New Guidelines on Hydroxychloroquine Dosage – Where Are We?
Background/Purpose: Hydroxychloroquine (HCQ) is a widely-used medication in many rheumatologic conditions. The most worrisome toxicity is irreversible damage to retinal pigment epithelium which can lead…Abstract Number: 2035 • 2017 ACR/ARHP Annual Meeting
Clinical Audit of Hydroxychloroquine Dosing and Toxicity Screening in Patients with Inflammatory Arthritis and Connective Tissue Diseases
Background/Purpose: Hydroxychloroquine (HCQ) is used widely for the treatment of inflammatory arthritides and systemic lupus erythematosus. Recent publications have shown that HCQ toxicity is not…
ACR Meeting Abstracts